Author: Brandon Malone; Boris Simovski; Clement Moline; Jun Cheng; Marius Gheorghe; Hugues Fontenelle; Ioannis Vardaxis; Simen Tennoe; Jenny-Ann Malmberg; Richard Stratford; Trevor Clancy
Title: Artificial intelligence predicts the immunogenic landscape of SARS-CoV-2: toward universal blueprints for vaccine designs Document date: 2020_4_21
ID: cm30gyd8_12
Snippet: Any viable vaccine to tackle SARS-CoV-2 that incorporates T cell epitopes in its design would need to contain a constellation of overlapping epitopes that protect the vast majority of the human HLA population against the virus. In this study we attempt to demonstrate that the SARS-CoV-2 immunogenic landscape clusters into distinct groups across the spectrum of HLA alleles in the human population. Our predicted immunogenic landscape of the SARS-Co.....
Document: Any viable vaccine to tackle SARS-CoV-2 that incorporates T cell epitopes in its design would need to contain a constellation of overlapping epitopes that protect the vast majority of the human HLA population against the virus. In this study we attempt to demonstrate that the SARS-CoV-2 immunogenic landscape clusters into distinct groups across the spectrum of HLA alleles in the human population. Our predicted immunogenic landscape of the SARS-CoV-2 virus is therefore then processed through a robust comprehensive statistical Monte Carlo simulation, incorporating the integrative immune parameters, to identify epitope hotspots for a broad adaptive immune response across the most common HLA genetic makeup in the human population. The resulting epitope hotspots we identified may represent areas in the viral proteome that are most likely to be viable vaccine targets and represent blueprints for vaccine designs that may be universal in nature.
Search related documents:
Co phrase search for related documents- cell epitope and epitope hotspot identify: 1
- cell epitope and HLA allele: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
- cell epitope and human HLA population: 1, 2, 3
- cell epitope and human population: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- cell epitope and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69
- cell epitope and immunogenic landscape: 1
- cell epitope and overlap epitope: 1, 2, 3
- cell epitope and result epitope: 1
- cell epitope and SARS virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37
- cell epitope and vaccine design: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- cell epitope and vaccine target: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
- cell epitope and vast majority: 1, 2, 3
- cell epitope and viable vaccine: 1
- distinct group and immune response: 1, 2
- distinct group and SARS virus: 1, 2, 3
- distinct group and vaccine design: 1
- distinct group and vast majority: 1, 2
- epitope hotspot and human HLA population: 1, 2, 3
- epitope hotspot and human population: 1, 2, 3
Co phrase search for related documents, hyperlinks ordered by date